Zelnick Kaufman Beth 4
4 · CorMedix Inc. · Filed Sep 11, 2025
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Zelnick Kaufman Beth
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-09-09$13.41/sh−49,600$665,136→ 180,818 total - Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-09-09−50,000→ 150,000 totalExercise: $3.30Exp: 2033-12-11→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2025-09-09$3.30/sh+50,000$165,000→ 230,418 total - Sale
Common Stock
2025-09-09$12.82/sh−400$5,128→ 180,418 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $12.83 to $13.82. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]These options were granted on 12/12/2023. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.